Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
170.92
86.54
40.62
110.25
120.65
50.12
146.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
170.92
86.54
40.62
110.25
120.65
50.12
146.13
Raw Material Cost
96.60
68.66
31.30
24.98
112.41
43.63
78.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.49
5.46
5.76
5.16
5.21
5.07
20.87
Selling and Distribution Expenses
47.66
8.50
68.15
89.11
28.94
11.74
85.49
Other Expenses
-0.34
-0.35
0.09
-0.43
-0.41
-0.13
-0.93
Total Expenditure (Excl Depreciation)
146.39
79.12
106.12
114.98
142.51
59.12
175.84
Operating Profit (PBDIT) excl Other Income
24.5
7.4
-65.5
-4.699999999999999
-21.9
-9
-29.700000000000003
Other Income
6.27
0.46
-39.70
7.03
10.83
-0.50
1.54
Operating Profit (PBDIT)
38.23
15.82
-139.39
11.10
-2.33
-1.38
-50.76
Interest
5.49
5.46
5.76
5.16
5.21
5.07
20.87
Exceptional Items
-5.51
1.50
-5.33
5.10
-0.21
-0.14
4.16
Gross Profit (PBDT)
74.32
17.88
9.32
85.27
8.24
6.49
67.37
Depreciation
8.57
8.57
9.32
9.32
8.80
8.80
9.66
Profit Before Tax
18.67
3.29
-159.79
1.72
-16.54
-15.38
-77.14
Tax
0.14
0.20
-0.28
0.23
-0.12
-0.12
3.85
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
18.16
2.96
-158.74
1.23
-17.11
-18.62
-83.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
18.16
2.96
-158.74
1.23
-17.11
-18.62
-83.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
18.16
2.96
-158.74
1.23
-17.11
-18.62
-83.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
641.40
623.24
620.28
735.30
734.07
751.14
769.76
Earnings per share (EPS)
0.03
0.0
-0.23
0.0
-0.02
-0.03
-0.12
Diluted Earnings per share
0.03
0.0
-0.23
0.0
-0.02
-0.03
-0.12
Operating Profit Margin (Excl OI)
13.68%
7.85%
-268.32%
-4.76%
-18.2%
-19.3%
-42.4%
Gross Profit Margin
15.93%
13.7%
-370.42%
10.01%
-6.42%
-13.14%
-46.17%
PAT Margin
10.62%
3.42%
-390.75%
1.12%
-14.18%
-37.15%
-57.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 41.59% vs 86.84% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 206.43% vs 29.92% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 342.42% vs 29.41% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 5.77% vs 271.43% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Lionco Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
170.92
0
170.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
170.92
0
170.92
Raw Material Cost
96.60
0
96.60
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.49
0
5.49
Selling and Distribution Expenses
47.66
0
47.66
Other Expenses
-0.34
0.00
-0.34
Total Expenditure (Excl Depreciation)
146.39
0
146.39
Operating Profit (PBDIT) excl Other Income
24.53
0.00
24.53
Other Income
6.27
0
6.27
Operating Profit (PBDIT)
38.23
0
38.23
Interest
5.49
0
5.49
Exceptional Items
-5.51
0
-5.51
Gross Profit (PBDT)
74.32
0
74.32
Depreciation
8.57
0
8.57
Profit Before Tax
18.67
0
18.67
Tax
0.14
0
0.14
Provisions and contingencies
0
0
0.00
Profit After Tax
18.16
0
18.16
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
18.16
0
18.16
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.16
0
18.16
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
641.40
0
641.40
Earnings per share (EPS)
0.03
0
0.03
Diluted Earnings per share
0.03
0
0.03
Operating Profit Margin (Excl OI)
13.68%
0%
0.00
13.68%
Gross Profit Margin
15.93%
0%
0.00
15.93%
PAT Margin
10.62%
0%
0.00
10.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 17.09 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 97.57% vs 113.05% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 41.59% vs 86.84% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.82 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 506.67% vs 101.89% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 206.43% vs 29.92% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.20 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 107.79% vs 115.45% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 342.42% vs 29.41% in Jun 2025
Quarterly - Interest
Interest 0.55 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 0.00% vs -5.17% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 5.77% vs 271.43% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.68%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
